News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,599 Results
Type
Article (13726)
Company Profile (101)
Press Release (250772)
Section
Business (88020)
Career Advice (465)
Deals (15341)
Drug Delivery (66)
Drug Development (36585)
Employer Resources (49)
FDA (6286)
Job Trends (6194)
News (150169)
Policy (14023)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (29)
Alliances (23206)
ALS (33)
Alzheimer's disease (379)
Antibody-drug conjugate (ADC) (34)
Approvals (6314)
Artificial intelligence (97)
Autoimmune disease (5)
Automation (3)
Bankruptcy (148)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (52)
Biotechnology (40)
Bladder cancer (17)
Brain cancer (15)
Breast cancer (72)
Cancer (541)
Cardiovascular disease (60)
Career advice (406)
Career pathing (10)
CAR-T (18)
Cell therapy (78)
Cervical cancer (4)
Clinical research (30805)
Collaboration (303)
Compensation (126)
Complete response letters (16)
COVID-19 (757)
CRISPR (18)
C-suite (103)
Cystic fibrosis (35)
Data (548)
Denatured (15)
Depression (9)
Diabetes (74)
Diagnostics (1311)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (62)
Drug shortages (12)
Duchenne muscular dystrophy (27)
Earnings (31946)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37310)
Executive appointments (334)
FDA (6635)
Featured Employer (20)
Friedreich's ataxia (2)
Funding (188)
Gene editing (35)
Generative AI (8)
Gene therapy (95)
GLP-1 (328)
Government (1282)
Grass and pollen (2)
Guidances (15)
Healthcare (3558)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (26)
Indications (11)
Infectious disease (788)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (36)
Interviews (59)
IPO (5873)
IRA (29)
Job creations (2050)
Job search strategy (372)
Kidney cancer (6)
Labor market (8)
Layoffs (175)
Leadership (3)
Legal (3428)
Liver cancer (19)
Lung cancer (74)
Lymphoma (49)
Machine learning (1)
Management (16)
Manufacturing (133)
MASH (28)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (9632)
Metabolic disorders (233)
Multiple sclerosis (16)
NASH (14)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (534)
NextGen: Class of 2025 (1585)
Non-profit (593)
Northern California (638)
Now hiring (7)
Obesity (133)
Opinion (116)
Ovarian cancer (18)
Pain (46)
Pancreatic cancer (13)
Parkinson's disease (41)
Partnered (5)
Patents (94)
Patient recruitment (26)
Peanut (9)
People (28811)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8017)
Phase II (13032)
Phase III (11694)
Pipeline (328)
Podcasts (44)
Policy (56)
Postmarket research (1401)
Preclinical (3196)
Press Release (25)
Prostate cancer (41)
Psychedelics (8)
Radiopharmaceuticals (119)
Rare diseases (154)
Real estate (2633)
Recruiting (17)
Regulatory (10040)
Reports (13)
Research institute (563)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (32)
Series A (32)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (651)
Special edition (6)
Sponsored (6)
Startups (1626)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6468)
Vaccines (143)
Venture capitalists (13)
Webinars (10)
Weight loss (91)
Women's health (8)
Worklife (3)
Date
Last 7 days (219)
Last 30 days (1023)
Last 365 days (12182)
2025 (2460)
2024 (12500)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (49)
Arkansas (3)
Asia (20038)
Australia (2598)
California (1550)
Canada (843)
China (198)
Colorado (63)
Connecticut (65)
Delaware (50)
Europe (39265)
Florida (284)
Georgia (34)
Idaho (9)
Illinois (171)
India (13)
Indiana (123)
Iowa (1)
Japan (79)
Kansas (54)
Kentucky (12)
Maine (2)
Maryland (237)
Massachusetts (1318)
Michigan (27)
Minnesota (84)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (671)
New Mexico (7)
New York (447)
North Carolina (366)
North Dakota (2)
Northern California (638)
Ohio (44)
Oklahoma (4)
Oregon (16)
Pennsylvania (388)
Puerto Rico (6)
Rhode Island (6)
South America (500)
South Carolina (2)
Southern California (651)
Tennessee (31)
Texas (205)
Utah (32)
Virginia (68)
Washington D.C. (29)
Washington State (107)
Wisconsin (14)
264,599 Results for "biomunex pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Biomunex Signs Exclusive Licensing Agreement With Institut Curie to Develop MAIT Engagers, a New Class of Bispecific Antibodies in Immuno-oncology
Biomunex Pharmaceuticals announced the signature of an exclusive license and exploitation agreement with Institut Curie.
March 4, 2024
·
5 min read
Press Releases
Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology
December 3, 2024
·
8 min read
Drug Development
Biomunex Pharmaceuticals Announces the Start of a Phase 1 Clinical Trial for Its First-in-class Bispecific Antibody for the Treatment of Cancer
This first-in-man trial conducted by Onward Therapeutics, under the license and co-development agreement, is a Phase 1 clinical trial for the evaluation of a bispecific antibody generated from Biomunex’ proprietary BiXAb® platform.
January 24, 2024
·
4 min read
Genetown
Biomunex Pharmaceuticals, a French Company Specialized in Immunotherapy, Presents the Latest Preclinical Results on Its Disruptive MAIT Cell Redirection Approach For Cancer Treatment at the 2023 AACR Annual Meeting
Biomunex Pharmaceuticals announced today that it will participate in and present new scientific data at the American Association for Cancer Research (AACR) annual meeting, which will take place from April 14th to April 19th, 2023 at the Orange County Convention Center, Orlando, Florida.
April 12, 2023
·
2 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology
Onward Therapeutics SA announced the execution of a worldwide exclusive license and co-development agreement with Biomunex Pharmaceuticals SAS, Paris, France, of a bispecific antibody targeting two immune checkpoints.
February 16, 2021
·
3 min read
Business
Biomunex Pharmaceuticals Establishes US Subsidiary
Biomunex Inc. to focus on R&D and business development activities in the US
May 28, 2019
·
3 min read
Press Releases
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
March 5, 2025
·
1 min read
Press Releases
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
1 of 26,460
Next
